Harrow Health News


Company Name Stock Ticker Symbol Market Type
Harrow Health Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 14.47 04:00:04
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
1/26/20237:21IHNWFeaturedUCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023
1/23/202307:21EDGARCurrent Report Filing (8-k)
1/23/202307:00BWHarrow Closes Acquisition of U.S. Rights to ILEVRO®,..
1/20/202317:01EDGARAmended Statement of Ownership (sc 13g/a)
1/05/202307:00BWHarrow Announces Availability of Fortisite™ Formulations for..
12/23/202207:04EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:03EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:02EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202207:01EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202209:21BWMelt Pharmaceuticals’ MELT-300 (Midazolam 3mg and Ketamine..
12/21/202206:04EDGARCertification by the Exchange Approving Securities for..
12/20/202216:46EDGARCurrent Report Filing (8-k)
12/19/202216:51EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/16/202207:00BWHarrow Secures Capital to Close Recently Announced..
12/14/202207:28DJNHarrow Health to Buy U.S. Rights to Novartis Drugs For Up to..
12/14/202206:49EDGARCurrent Report Filing (8-k)
12/14/202206:46EDGARCurrent Report Filing (8-k)
12/14/202206:44EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/14/202206:32BWHarrow Announces Proposed Offering of $100 Million of Senior..
12/14/202206:31BWHarrow Prices $25 Million Offering
12/14/202206:30BWHarrow Enters into Agreement to Acquire Exclusive U.S...
11/30/202208:00BWHarrow and iOR Partners Expand National Product Supply..
11/14/202216:49EDGARQuarterly Report (10-q)
11/14/202216:41EDGARCurrent Report Filing (8-k)
11/14/202216:05BWHarrow Announces Third Quarter 2022 Financial Results
11/10/202208:00BWHarrow Launches
10/28/202208:00BWHarrow to Announce Third Quarter 2022 Financial Results on..
10/27/202208:00BWMelt Pharmaceuticals Announces Dosing of Last Patient in..
10/06/202210:05TRMNB.Riley Financial Sticks to Their Buy Rating for Harrow..
10/05/202217:35BWHarrow Sells Non-Ophthalmic Compounding Business
10/05/202217:28EDGARCurrent Report Filing (8-k)
10/03/202218:03EDGARStatement of Changes in Beneficial Ownership (4)
9/30/202206:16EDGARStatement of Changes in Beneficial Ownership (4)
9/29/202207:00BWImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin..
9/27/202216:55TRMNB.Riley Financial Remains a Buy on Harrow Health (HROW)
9/27/202215:28TRMNWhy Harrow Health Stock (NASDAQ:HROW) Soared Today
9/27/202213:50BWHarrow Announces U.S. FDA Approval of IHEEZO™..
9/22/202207:45EDGARCurrent Report Filing (8-k)
9/07/202213:15TRMNHarrow Health (HROW) Receives a New Rating from B.Riley..
8/11/202208:00BWHarrow Health to Participate in H.C. Wainwright 2nd Annual..
8/09/202216:37EDGARQuarterly Report (10-q)
8/09/202216:18EDGARCurrent Report Filing (8-k)
8/09/202216:01BWHarrow Health Announces Second Quarter 2022 Financial..
7/27/202207:00BWHarrow Health to Announce Second Quarter 2022 Financial..
6/24/202208:00BWHarrow Health Announces Launch of IOPIDINE® 1% and MAXITROL®..
6/13/202216:37EDGARCurrent Report Filing (8-k)
6/10/202218:05EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202217:56EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202206:04EDGARNotice of Effectiveness (effect)
5/26/202217:11EDGARSecurities Registration Statement (simplified Form) (s-3)